Categories: HealthcareNews

SS&C Increases Common Stock Dividend to $0.25 Per Share

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WINDSOR, Conn., Aug. 21, 2024 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced its Board of Directors has approved a quarterly dividend payout of $0.25 per share, up from $0.24 per share. The dividend is payable on September 16, 2024, to stockholders of record as of the close of business on September 3, 2024.

Bill Stone, Chairman and CEO, commented: “SS&C continues to grow, generating net cash from operating activities of $385 million in the second quarter – up 16.8% from the same period a year ago. Our goal is to create long-term shareholder value, which includes increases to our dividend as part of our capital allocation strategy. SS&C sees many opportunities ahead, and we will continue to exercise prudent cash flow management.”

About SS&C Technologies

SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 20,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on Twitter, LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ssc-increases-common-stock-dividend-to-0-25-per-share-302227902.html

SOURCE SS&C

Staff

Recent Posts

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

3 hours ago

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4…

5 hours ago

Healthcare Analytical Testing Services Market worth $12.48 billion by 2030 with 10.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market,…

6 hours ago

Dynamic Infrastructure Partners with The Advocacy Partners to Accelerate AI-Driven Bridge Maintenance Across Florida

TALLAHASSEE, Fla., July 25, 2025 /PRNewswire/ -- Dynamic Infrastructure (diglobal.tech), the leading provider of AI-powered…

6 hours ago

Weekly Recap: 12 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's…

6 hours ago

Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE:…

8 hours ago